Perfil lipídico e fatores biológicos e ambientais : o papel da atividade física

RESUMO - Introdução: A inatividade física é um dos determinantes major das doenças crónicas não transmissíveis sendo a quarta maior causa de mortalidade no mundo, nomeadamente para as doenças vasculares. A prática regular de atividade física produz adaptações vasculares responsáveis por efeitos benéficos na prevenção e tratamento dos diferentes fatores de risco vascular, nomeadamente através do seu efeito no metabolismo das lipoproteínas. Objetivos: Analisar a interferência da atividade física no perfil lipídico de uma população residente em Portugal. Métodos: Estudo observacional descritivo transversal exploratório com 1027 indivíduos (idade: 18 aos 80 anos, 49% mulheres). Os dados foram analisados em SPSS (versão 20), tendo-se utilizado métodos de estatística descritiva e de análise bivariável entre os factores de risco vascular e as variáveis do perfil lipídico e ainda uma análise multivariável de regressão logística binária para medir a razão de riscos pelo odds ratio. O nível de significância foi estabelecido em 5%. Resultados: Na análise da relação entre atividade física e os biomarcadores do perfil lipídico verificou-se que existem benefícios no que diz respeito ao aumento dos níveis de HDL e de apoA1 e na diminuição dos níveis de TG com a prática regular de atividade física. Conclusões: A atividade física apresenta um papel importante na regulação do perfil lipídico evidenciando a necessidade de implementar estratégias multissectoriais de prevenção dos fatores de risco vascular, nomeadamente na área dos estilos de vida saudáveis que são fundamentais para a prevenção destas condições de saúde e para gerar ganhos em saúde.

Intervenção breve no tabagismo : abordagem clínica dos médicos portugueses

RESUMO - O tabagismo é o principal factor de risco evitável em saúde nos países europeus, contribuindo para o aumento da mortalidade prematura, estando associado a inúmeras doenças. A epidemia tabágica é uma preocupação em Saúde Pública, sendo essencial o investimento na sua prevenção e controlo. A cessação tabágica é uma das estratégias para o controlo desta epidemia, surgindo a intervenção breve como uma comprovada medida custo-efetiva. Contudo, e apesar das guidelines, a intervenção breve não está amplamente disseminada na prática clínica dos profissionais de saúde. Neste sentido, este estudo teve como objetivo avaliar as práticas clíniicas autoreportadas dos médicos portugueses na intervenção breve em tabagismo. É um estudo observacional descritivo transversal e exploratório. A amostra é constituída por médicos que participaram em duas conferências médicas distintas e que aceitaram responder a um questionário (n=549). O tratamento estatístico foi efetuado recorrendo ao Statistical Package for the Social Sciences (SPSS), versão 21. Foram efetuadas uma análise descritiva e inferencial, assim como uma regressão logística. Analisando os dados, os resultados apontam para a formação pós-graduada e a prática de cessação tabágica como dois fatores que influenciam positivamente a atuação dos médicos na intervenção breve. A intervenção breve é fundamental para aumentar as taxas de cessação tabágica. Para que a implementação seja eficaz é necessário apostar na formação pré e pós-graduada dos médicos e outros profissionais de saúde, associando essa formação ao treino prático que possibilite o desenvolvimento de competências específicas.

Factores sociodemográficos na saúde oral : influências nos comportamentos de rotinas de saúde oral, frequências de idas a consultas, auto avaliação do estado de saúde oral e presença de dor em jovens de 12 anos

RESUMO - Introdução: A saúde oral é uma componente essencial na saúde geral e no bem-estar dos indivíduos. Sabe-se que os problemas de saúde oral afectam predominantemente os elementos de níveis socioeconómicos mais baixos, evidenciando a influência dos determinantes sociais da saúde na saúde oral das populações. Os objectivos deste estudo são caracterizar os comportamentos de rotinas diárias de higiene oral, frequências de idas a consultas de saúde oral, auto-avaliação do estado de saúde oral e percepção de dor na cavidade oral em crianças de 12 anos em Portugal e analisar a associação entre estes e os factores sociodemográficos. Métodos: Foi realizado um estudo observacional, transversal e analítico, abrangendo 1309 jovens e baseado em informação recolhida no III Estudo Nacional de Prevalência de Doenças Orais (ENPDO). Para além das estatísticas descritivas usuais, as estatísticas inferenciais basearam-se predominantemente em modelos de regressão logística binária. Resultados: Dos participantes, 70.6% (n=924) escova “duas ou mais vezes por dia” com associação com todas as variáveis sociodemográficas. Na análise multivariada, o género masculino (OR=2.088; IC95%: 1.574-2.770, em relação ao género feminino), a área de residência predominantemente rural ou mediamente urbana (OR= 1.800; IC95%: 2.587; OR=1.516; IC95%: 1.093-2.103, em relação a zonas predominantemente urbanas), a escolaridade da mãe ser o ensino básico (OR= 2.112; IC95%: 1.408-3.168, em relação ao ensino superior) e a actividade laboral do pai ser desempregado (OR= 1.938; IC95%: 1.280-2.934, em relação a ser trabalhador) foram as variáveis com mais impacto para a adopção de comportamentos de escovagem potencialmente inadequados (p<0.05). A maioria dos inquiridos (94.2%; n=1247) já tinham ido a uma consulta de saúde oral e 74.5% (n=860) nos últimos 12 meses, 95.5% (n=1250) encontram-se satisfeitos com a saúde oral e 44.5% (n=578) afirma ter tido algum tipo de dor na cavidade oral nos últimos 12 meses. Conclusão: Os resultados obtidos estão de acordo com a literatura em termos de factores de associação. Desta forma, a saúde oral nos jovens de 12 anos em Portugal, nos diversos contextos aqui analisados, pode ser considerada como satisfatória. A única excepção relevante é a componente da dor, com valores alarmantes embora de natureza mais subjectiva. A influência dos factores sociodemográficos sugere que futuras abordagens para a promoção da saúde oral tenham em conta os determinantes de saúde no delineamento de estratégias quer a nível individual quer a nível comunitário.

Prevalência do excesso de peso em idade pré-escolar no concelho da Murtosa: um estudo transversal

RESUMO - A prevalência de obesidade infantil em Portugal é das mais elevadas da Europa. No concelho da Murtosa (Aveiro), para estimar a prevalência de excesso de peso e obesidade entre os 3 e os 6 anos e determinar os factores que lhe estão associados, desenvolveu-se, durante o ano de 2008, um estudo transversal que consistiu na avaliação estatoponderal das crianças frequentadoras dos estabelecimentos de ensino pré-escolar do concelho e aplicação de um questionário aos pais sobre antecedentes e perinatais, hábitos alimentares, actividades da criança e características da família. Através de um modelo de regressão logística multivariada identificaram-se as variáveis associadas ao excesso de peso/obesidade. Participaram no estudo 258 crianças, estimando-se uma prevalência de excesso de peso de 15,5 % (IC 95 % : 11,6 % a 20,4 %) e de obesidade de 6,2 % (IC 95 % : 3,9 % a 9,8 % ). Observou-se uma maior prevalência de excesso de peso nos meninos (19,5 %) e de obesidade nas meninas (10,4 %). O excesso de peso materno e o hábito de comer a ver televisão aumentaram o risco de excesso de peso/obesidade (OR: 10,548; OR: 13,815); o maior número de horas de sono diário, o maior número de refeições diárias e o aumento ponderal materno durante a gravidez (OR: 0,490; OR: 0,366; OR: 0,804) associaram-se a um menor risco de excesso de peso/obesidade. Justifica-se o desenvolvimento de programas de prevenção primária e secundária da obesidade infantil dirigidos aos factores de risco modificáveis identificados, sugerindo-se a necessidade de uma abordagem familiar e da avaliação sistemática deste tipo de intervenções.

Desigualdades sociais em saúde nos idosos : um retrato para Portugal

RESUMO - Contexto: As desigualdades sociais em saúde são uma questão central de justiça social. No contexto de forte envelhecimento populacional em Portugal, as desigualdades nos idosos representam um desafio crucial para o futuro, sobre as quais existe pouca evidência. Este estudo pretende investigar a existência de desigualdades socioeconómicas em saúde nos idosos, em Portugal. Metodologia: Foram utilizados os dados para Portugal, da quarta vaga do Survey of Health, Ageing and Retirement in Europe. O estudo engloba 2017 indivíduos com 50 ou mais anos. Foram utilizados quatro indicadores de saúde: problemas de saúde, saúde auto-reportada, doenças de longa duração e atividade limitada. Foi utilizado o nível de educação como indicador socioeconómico. As desigualdades socioeconómicas foram avaliadas através de regressões logísticas multivariadas. Resultados: Existem desigualdades socioeconómicas em saúde nos idosos favoráveis aos mais educados. Os indivíduos com menor educação estão em maior risco de reportar má saúde (OR=5,5); maior risco em ter problemas de saúde, existindo um gradiente social na Hipertensão Arterial (OR=2,4) e na Artrite (OR=7,0); maior risco de doenças de longa duração (OR=1,6) e maior risco de limitação nas atividades diárias (OR=5,1). As desigualdades socioeconómicas diminuem com a idade. Conclusão: De forma a melhorar a saúde e reduzir as desigualdades socioeconómicas em saúde nos idosos, os resultados apontam para a necessidade de implementar medidas no âmbito dos problemas de saúde em que existe um gradiente social, melhorar o nível de educação da população geral e implementar medidas de educação para a saúde, aumentando a literacia em saúde nos idosos mais jovens.

Scenario-based assessment of future land use change on butterfly species distributions

Species distribution models (SDMs) are increasingly used to predict environmentally induced range shifts of habitats of plant and animal species. Consequently SDMs are valuable tools for scientifically based conservation decisions. The aims of this paper are (1) to identify important drivers of butterfly species persistence or extinction, and (2) to analyse the responses of endangered butterfly species of dry grasslands and wetlands to likely future landscape changes in Switzerland. Future land use was represented by four scenarios describing: (1) ongoing land use changes as observed at the end of the last century; (2) a liberalisation of the agricultural markets; (3) a slightly lowered agricultural production; and (4) a strongly lowered agricultural production. Two model approaches have been applied. The first (logistic regression with principal components) explains what environmental variables have significant impact on species presence (and absence). The second (predictive SDM) is used to project species distribution under current and likely future land uses. The results of the explanatory analyses reveal that four principal components related to urbanisation, abandonment of open land and intensive agricultural practices as well as two climate parameters are primary drivers of species occurrence (decline). The scenario analyses show that lowered agricultural production is likely to favour dry grassland species due to an increase of non-intensively used land, open canopy forests, and overgrown areas. In the liberalisation scenario dry grassland species show a decrease in abundance due to a strong increase of forested patches. Wetland butterfly species would decrease under all four scenarios as their habitats become overgrown

The occurrence of intra-operative hypotension varies between hospitals: observational analysis of more than 147,000 anaesthesia.

BACKGROUND: Hypotension, a common intra-operative incident, bears an important potential for morbidity. It is most often manageable and sometimes preventable, which renders its study important. Therefore, we aimed at examining hospital variations in the occurrence of intra-operative hypotension and its predictors. As secondary endpoints, we determined to what extent hypotension relates to the risk of post-operative incidents and death. METHODS: We used the Anaesthesia Databank Switzerland, built on routinely and prospectively collected data on all anaesthesias in 21 hospitals. The three outcomes were assessed using multi-level logistic regression models. RESULTS: Among 147,573 anaesthesias, hypotension ranged from 0.6% to 5.2% in participating hospitals, and from 0.3% up to 12% in different surgical specialties. Most (73.4%) were minor single events. Age, ASA status, combined general and regional anaesthesia techniques, duration of surgery and hospitalization were significantly associated with hypotension. Although significantly associated, the emergency status of the surgery had a weaker effect. Hospitals' odds ratios for hypotension varied between 0.12 and 2.50 (P < or = 0.001), even after adjusting for patient and anaesthesia factors, and for type of surgery. At least one post-operative incident occurred in 9.7% of the procedures, including 0.03% deaths. Intra-operative hypotension was associated with a higher risk of post-operative incidents and death. CONCLUSION: Wide variations remain in the occurrence of hypotension among hospitals after adjustment for risk factors. Although differential reporting from hospitals may exist, variations in anaesthesia techniques and blood pressure maintenance may also have contributed. Intra-operative hypotension is associated with morbidities and sometimes death, and constant vigilance must thus be advocated.

A novel gene expression signature in peripheral blood mononuclear cells for early detection of colorectal cancer.

BACKGROUND: Early detection and treatment of colorectal adenomatous polyps (AP) and colorectal cancer (CRC) is associated with decreased mortality for CRC. However, accurate, non-invasive and compliant tests to screen for AP and early stages of CRC are not yet available. A blood-based screening test is highly attractive due to limited invasiveness and high acceptance rate among patients. AIM: To demonstrate whether gene expression signatures in the peripheral blood mononuclear cells (PBMC) were able to detect the presence of AP and early stages CRC. METHODS: A total of 85 PBMC samples derived from colonoscopy-verified subjects without lesion (controls) (n = 41), with AP (n = 21) or with CRC (n = 23) were used as training sets. A 42-gene panel for CRC and AP discrimination, including genes identified by Digital Gene Expression-tag profiling of PBMC, and genes previously characterised and reported in the literature, was validated on the training set by qPCR. Logistic regression analysis followed by bootstrap validation determined CRC- and AP-specific classifiers, which discriminate patients with CRC and AP from controls. RESULTS: The CRC and AP classifiers were able to detect CRC with a sensitivity of 78% and AP with a sensitivity of 46% respectively. Both classifiers had a specificity of 92% with very low false-positive detection when applied on subjects with inflammatory bowel disease (n = 23) or tumours other than CRC (n = 14). CONCLUSION: This pilot study demonstrates the potential of developing a minimally invasive, accurate test to screen patients at average risk for colorectal cancer, based on gene expression analysis of peripheral blood mononuclear cells obtained from a simple blood sample.

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.

BACKGROUND & AIMS: Hepatitis C virus (HCV) induces chronic infection in 50% to 80% of infected persons; approximately 50% of these do not respond to therapy. We performed a genome-wide association study to screen for host genetic determinants of HCV persistence and response to therapy. METHODS: The analysis included 1362 individuals: 1015 with chronic hepatitis C and 347 who spontaneously cleared the virus (448 were coinfected with human immunodeficiency virus [HIV]). Responses to pegylated interferon alfa and ribavirin were assessed in 465 individuals. Associations between more than 500,000 single nucleotide polymorphisms (SNPs) and outcomes were assessed by multivariate logistic regression. RESULTS: Chronic hepatitis C was associated with SNPs in the IL28B locus, which encodes the antiviral cytokine interferon lambda. The rs8099917 minor allele was associated with progression to chronic HCV infection (odds ratio [OR], 2.31; 95% confidence interval [CI], 1.74-3.06; P = 6.07 x 10(-9)). The association was observed in HCV mono-infected (OR, 2.49; 95% CI, 1.64-3.79; P = 1.96 x 10(-5)) and HCV/HIV coinfected individuals (OR, 2.16; 95% CI, 1.47-3.18; P = 8.24 x 10(-5)). rs8099917 was also associated with failure to respond to therapy (OR, 5.19; 95% CI, 2.90-9.30; P = 3.11 x 10(-8)), with the strongest effects in patients with HCV genotype 1 or 4. This risk allele was identified in 24% of individuals with spontaneous HCV clearance, 32% of chronically infected patients who responded to therapy, and 58% who did not respond (P = 3.2 x 10(-10)). Resequencing of IL28B identified distinct haplotypes that were associated with the clinical phenotype. CONCLUSIONS: The association of the IL28B locus with natural and treatment-associated control of HCV indicates the importance of innate immunity and interferon lambda in the pathogenesis of HCV infection.

Coffee and tea intake and risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.

BACKGROUND: Only a few studies have explored the relation between coffee and tea intake and head and neck cancers, with inconsistent results. METHODS: We pooled individual-level data from nine case-control studies of head and neck cancers, including 5,139 cases and 9,028 controls. Logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (95% CI), adjusting for potential confounders. RESULTS: Caffeinated coffee intake was inversely related with the risk of cancer of the oral cavity and pharynx: the ORs were 0.96 (95% CI, 0.94-0.98) for an increment of 1 cup per day and 0.61 (95% CI, 0.47-0.80) in drinkers of >4 cups per day versus nondrinkers. This latter estimate was consistent for different anatomic sites (OR, 0.46; 95% CI, 0.30-0.71 for oral cavity; OR, 0.58; 95% CI, 0.41-0.82 for oropharynx/hypopharynx; and OR, 0.61; 95% CI, 0.37-1.01 for oral cavity/pharynx not otherwise specified) and across strata of selected covariates. No association of caffeinated coffee drinking was found with laryngeal cancer (OR, 0.96; 95% CI, 0.64-1.45 in drinkers of >4 cups per day versus nondrinkers). Data on decaffeinated coffee were too sparse for detailed analysis, but indicated no increased risk. Tea intake was not associated with head and neck cancer risk (OR, 0.99; 95% CI, 0.89-1.11 for drinkers versus nondrinkers). CONCLUSIONS: This pooled analysis of case-control studies supports the hypothesis of an inverse association between caffeinated coffee drinking and risk of cancer of the oral cavity and pharynx. IMPACT: Given widespread use of coffee and the relatively high incidence and low survival of head and neck cancers, the observed inverse association may have appreciable public health relevance.

Relationships between imatinib plasma levels and efficacy

Purpose: While imatinib has revolutionized the treatment of chronic myeloid leukaemia (CML) and gastrointestinal stromal tumors (GIST), its pharmacokinetic-pharmacodynamic relationships have been poorly studied. This study aimed to explore the issue in oncologic patients, and to evaluate the specific influence of the target genotype in a GIST subpopulation. Patients and methods: Data from 59 patients (321 plasma samples) were collected during a previous pharmacokinetic study. Based on a population model purposely developed, individual post-hoc Bayesian estimates of pharmacokinetic parameters were derived, and used to estimate drug exposure (AUC; area under curve). Free fraction parameters were deduced from a model incorporating plasma alpha1-acid glycoprotein levels. Associations between AUC (or clearance) and therapeutic response (coded on a 3-point scale), or tolerability (4-point scale), were explored by ordered logistic regression. Influence of KIT genotype on response was also assessed in GIST patients. Results: Total and free drug exposure correlated with the number of side effects (p < 0.005). A relationship with response was not evident in the whole patient set (with good-responders tending to receive lower doses and bad-responders higher doses). In GIST patients however, higher free drug exposure predicted better responses. A strong association was notably observed in patients harboring an exon 9 mutation or a wild type KIT, known to decrease tumor sensitivity towards imatinib (p < 0.005). Conclusions: Our results are arguments to further evaluate the potential benefit of a therapeutic monitoring program for imatinib. Our data also suggest that stratification by genotype will be important in future trials.

Outcome and Experience from the Swiss Mammography Screening Pilot Programmes

BACKGROUND:The Swiss breast cancer screening pilot programme was conducted in 3 districts of theFrench-speaking canton of Vaud (ca. 300,000 resident women) between October 1993 and January 1999.Women aged 50 to 69 were invited by mail every 2 years for a free of charge screening mammography (doubleview, multiple reading). This first ever-organised cancer screening programme in Switzerland showed thefeasibility and acceptability of this kind of public health intervention in the liberal Swiss healthcare system, whichwas the main objective of the pilot programme. This mammographic screening programme was extended to thewhole canton in 1999, and contributed to the implementation of similar programmes in 2 neighbouring cantons. OBJECTIVE:To appraise the use, the quality and the effectiveness of the Swiss screening pilot programme. METHODS:About 15,000 women (aged 50-69) were enrolled. Logistic regression analyses were performedseparately to identify determinants of initial and subsequent attendance. Standard indicators of quality,effectiveness and impact of the programme were assessed and compared with European recommendations. Tothis intent, linkage with data from the Vaud Cancer Registry was performed. RESULTS:About half the target population was screened at least once during the pilot trial. Participation washigher among Swiss than foreigners, among widowed or married women than among single, divorced or separatedones. Attendance also increased with age and decreasing distance between residence and the dedicatedscreening centre. Apart from Swiss citizenship, socio-demographic factors were not associated with reattendance.Intensity of prior recruitment, outcome of previous screening test (positive vs. negative) and indicators of women'shealth behaviour (time of last mammography prior to initial screen, smoking status) were the main determinants ofreattendance. Programme performance and quality indicators were, overall, in line with European Guidelines. Theywere overall more favourable among 60-69 than 50-59 year-olds and improved over time. CONCLUSION:The objectives of the pilot programme were met. Even if participation should increase in order toreach European standards, performance indicators overall met quality requirements. Ways to improve screeninguse, quality and effectiveness were devised and taken into account for the generalisation of the programme.

Thrombolysis in ischemic stroke without arterial occlusion at presentation.

BACKGROUND AND PURPOSE: None of the randomized trials of intravenous tissue-type plasminogen activator reported vascular imaging acquired before thrombolysis. Efficacy of tissue-type plasminogen activator in stroke without arterial occlusion on vascular imaging remains unknown and speculative. METHODS: We performed a retrospective, multicenter study to collect data of patients who presented to participating centers during a 5-year period with ischemic stroke diagnosed by clinical examination and MRI and with imaging evidence of no vascular occlusion. These patients were divided into 2 groups: those who received thrombolytic therapy and those who did not. Primary outcome measure of the study was excellent clinical outcome defined as modified Rankin Scale of 0 to 1 at 90 days from stroke onset. Secondary outcome measures were good clinical outcome (modified Rankin Scale, 0-2) and perfect outcome (modified Rankin Scale, 0). Safety outcome measures were incidence of symptomatic intracerebral hemorrhage and poor outcome (modified Rankin Scale, 4-6). RESULTS: A total of 256 patients met study criteria, 103 with thrombolysis and 153 without. Logistic regression analysis showed that patients who received thrombolysis had more frequent excellent outcomes with odds ratio of 3.79 (P<0.01). Symptomatic intracerebral hemorrhage was more frequent in thrombolysis group (4.9 versus 0.7%; P=0.04). Thrombolysis led to more frequent excellent outcome in nonlacunar group with odds ratio 4.90 (P<0.01) and more frequent perfect outcome in lacunar group with odds ratio 8.25 (P<0.01). CONCLUSIONS: This study provides crucial data that patients with ischemic stroke who do not have visible arterial occlusion at presentation may benefit from thrombolysis.

Periodontitis and gingivitis in inflammatory bowel disease: a case-control study.

BACKGROUND: The oral cavity is frequently affected in patients with inflammatory bowel disease (IBD), especially in patients with Crohn's disease (CD). Periodontitis is thought to influence systemic autoimmune or inflammatory diseases. We aimed to analyze the relationship of periodontitis and gingivitis markers with specific disease characteristics in patients with IBD and to compare these data with healthy controls. METHODS: In a prospective 8-month study, systematic oral examinations were performed in 113 patients with IBD, including 69 patients with CD and 44 patients with ulcerative colitis. For all patients, a structured personal history was taken. One hundred thirteen healthy volunteers served as a control group. Oral examination focussed on established oral health markers for periodontitis (bleeding on probing, loss of attachment, and periodontal pocket depth) and gingivitis (papilla bleeding index). Additionally, visible oral lesions were documented. RESULTS: Both gingivitis and periodontitis markers were higher in patients with IBD than in healthy control. In univariate analysis and logistic regression analysis, perianal disease was a risk factor for periodontitis. Nonsmoking decreased the risk of having periodontitis. No clear association was found between clinical activity and periodontitis in IBD. In only the CD subgroup, high clinical activity (Harvey-Bradshaw index > 10) was associated with 1 periodontitis marker, the loss of attachment at sites of maximal periodontal pocket depth. Oral lesions besides periodontitis and gingivitis were not common, but nevertheless observed in about 10% of patients with IBD. CONCLUSIONS: IBD, and especially perianal disease in CD, is associated with periodontitis. Optimal therapeutic strategies should probably focus on treating both local oral and systemic inflammation.